The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. The metric has seen a significant loss of -18.39% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -15.97%. Over the past 30 days, the price of KZR has fallen by 29.30%. And in the last five days, it has surged by 36.46%.
In terms of market performance, Kezar Life Sciences Inc had a fairly uneven. The highest value for the stock in the past year was $1.20 on 10/02/23, and the lowest value was recorded at $0.52 on 09/26/24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
52-week price history of KZR Stock
Examining the 52-week high and low prices can provide valuable insights into a stock’s current status and future performance. Kezar Life Sciences Inc’s current trading price is -35.57% away from its 52-week high, while its distance from the 52-week low is 48.64%. The stock’s price range during this time has been between $0.52 and $1.20. The trading volume for the Healthcare sector company’s shares reached about 16.15 million for the day, which was higher than the average daily volume of 0.52 million over the last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Kezar Life Sciences Inc (KZR) has experienced a quarterly rise of 32.49% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 56.41M and boasts a workforce of 58 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.6416, with a change in price of -0.0668. Similarly, Kezar Life Sciences Inc recorded 690,375 in trading volume during the last 100 days, posting a change of -7.95%.
KZR’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for KZR stands at 0.12. Similarly, the long-term debt-to-equity ratio is also 0.08.
KZR Stock Stochastic Average
Today’s raw stochastic average for Kezar Life Sciences Inc over the last 50 days is 82.68%.This indicates a increase from the raw stochastic average of the past 20 days, which was 82.68%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 37.86% and 20.35%, respectively.
